C1q helps AML to disseminate and resist
- 16 February 2023
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 141 (7) , 691-692
Abstract
In this issue of Blood, Yang et al1 identified that the complement component 1q (C1q) may facilitate both the dissemination of acute myeloid leukemia (AML) outsKeywords
This publication has 9 references indexed in Scilit:
- C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapseBlood, 2023
- Clonal Architecture and Evolutionary Dynamics in Acute Myeloid LeukemiasCancers, 2021
- Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolvedBlood Reviews, 2021
- The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6Clinical Cancer Research, 2017
- Extramedullary acute myelogenous leukemiaBlood Reviews, 2016
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to ResistanceCancer Cell, 2012
- The C1q Family of Proteins: Insights into the Emerging Non-Traditional FunctionsFrontiers in Immunology, 2012
- Cell-surface Receptor for Complement Component C1q (gC1qR) Is a Key Regulator for Lamellipodia Formation and Cancer MetastasisJournal of Biological Chemistry, 2011
- Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantationCancer, 1999